Brazil probes vaccine contract with India’s Bharat Biotech
Al Jazeera
Prosecutors cite the drug’s high price, speedy talks and pending regulatory approvals as red flags for the contract.
Brazilian federal prosecutors have opened an investigation into a contract worth 1.6 billion reals ($320m) for 20 million doses of a COVID-19 vaccine made by India’s Bharat Biotech, according to a document seen by Reuters. The prosecutor-general’s office (PGR) cited comparatively high prices, speedy talks and pending regulatory approvals as red flags for the Bharat contract signed in February, before similar deals with Pfizer Inc and Johnson & Johnson. Bharat did not respond to a request for comment outside of business hours in India.More Related News